amikacin has been researched along with cefsulodin in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (87.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beaufils, F; Bingen, E; Guihaire, E; Lambert-Zechovsky, N; Mercier, JC; Nancy, C | 1 |
Bale, M; Howard, W; Koontz, F; Pfaller, M; Preston, T | 1 |
Baltch, AL; Bassey, C; Fanciullo, G; Smith, RP | 1 |
Bailey, EJ; Chandrasekar, PH; Crane, LR | 1 |
Canawati, HN; Gilmore, DS; Graham, IE; Ibraham, MZ; Montgomerie, JZ; Morrow, JW | 1 |
Aznar, J; Iglesias, MC; Martin, E; Nogales, MC; Perea, EJ | 1 |
Burghoffer, B; Daguet, GL; Petit, JC; Richard, G | 1 |
Ben Hassen, A; Ben Rejeb, S; Ghozzi, R; Hammami, A; Jouaihia, W; Kalai, S; Kechrid, A; Mahjoubi, F; Thabet, L | 1 |
8 other study(ies) available for amikacin and cefsulodin
Article | Year |
---|---|
[Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefsulodin; Ceftazidime; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas aeruginosa; Ticarcillin | 1986 |
In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Time Factors; Tobramycin | 1986 |
In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefsulodin; Clindamycin; Drug Combinations; Drug Synergism; Enoxacin; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Naphthyridines; Oxacillin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin | 1987 |
Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patients.
Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefsulodin; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin; Tobramycin | 1987 |
Cefsulodin in treatment of Pseudomonas urinary tract infection in patients with spinal cord injury. Comparison with aminoglycosides.
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefsulodin; Humans; Male; Middle Aged; Pseudomonas Infections; Spinal Cord Injuries; Time Factors; Tobramycin; Urinary Tract Infections | 1986 |
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Cefsulodin; Cephalosporins; Dibekacin; Drug Synergism; Gentamicins; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1980 |
[Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Cefsulodin; Ceftazidime; Cephalosporins; Drug Synergism; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1982 |
[Pseudomonas aeruginosa: a multicentric study of antibiotic resistance (1999-2000)].
Topics: Amikacin; Anti-Bacterial Agents; Cefsulodin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Hospitals, University; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Surgery Department, Hospital; Ticarcillin; Tunisia | 2004 |